{"id":"NCT02291861","sponsor":"Auspex Pharmaceuticals, Inc.","briefTitle":"Addressing Involuntary Movements in Tardive Dyskinesia","officialTitle":"A Randomized, Double-Blind, Placebo-Controlled, Fixed-Dose Study of SD-809 (Deutetrabenazine) for the Treatment of Moderate to Severe Tardive Dyskinesia","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-10-31","primaryCompletion":"2016-08-19","completion":"2016-08-19","firstPosted":"2014-11-17","resultsPosted":"2018-04-11","lastUpdate":"2021-11-09"},"enrollment":298,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Tardive Dyskinesia"],"interventions":[{"type":"DRUG","name":"SD-809","otherNames":["deutetrabenzine","Austedo"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"SD-809 12 mg/day","type":"EXPERIMENTAL"},{"label":"SD-809 24 mg/day","type":"EXPERIMENTAL"},{"label":"SD-809 36 mg/day","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to determine whether fixed-doses of an investigational drug, SD-809 (deutetrabenazine), will reduce the severity of abnormal involuntary movements of tardive dyskinesia.","primaryOutcome":{"measure":"Change in Total Motor Abnormal Involuntary Movement Scale (AIMS) Score From Baseline to Week 12 Using a Mixed Model For Repeated Measures (MMRM)","timeFrame":"Day 0 (Baseline), Weeks 2, 4, 8 and 12","effectByArm":[{"arm":"Placebo","deltaMin":-1.4,"sd":0.41},{"arm":"SD-809 12 mg/Day","deltaMin":-2.1,"sd":0.42},{"arm":"SD-809 24 mg/Day","deltaMin":-3.2,"sd":0.45},{"arm":"SD-809 36 mg/Day","deltaMin":-3.3,"sd":0.42}],"pValues":[{"comp":"OG000 vs OG003","p":"0.001"},{"comp":"OG000 vs OG002","p":"0.003"},{"comp":"OG000 vs OG001","p":"0.217"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":8,"exclusionCount":11},"locations":{"siteCount":106,"countries":["United States","Czechia","Germany","Hungary","Poland","Slovakia"]},"refs":{"pmids":["28668671","38557959"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":4,"n":72},"commonTop":["Headache","Diarrhoea","Nausea","Nasopharyngitis"]}}